CJC-1295 at a glance
| Detail | What the sources say |
|---|---|
| What it is | Synthetic GHRH(1-29) analogue with four amino-acid substitutions |
| Two forms | With DAC (binds albumin, lasts days) and without DAC (modified GRF 1-29) |
| Human data | Studies in healthy adults with the DAC form; no published human studies of the form without DAC |
| Approved medicine? | No (FDA, EMA) |
| Clinical trial | NCT00267527 (HIV with visceral obesity), terminated |
From the sources to the app
| What the sources say | What PepLabo does with it |
|---|---|
| Half-lives in the literature differ widely between the DAC and non-DAC forms [1]. | PepLabo draws a level chart only when the library half-life matches your route, or from a half-life you enter yourself. |
| Neither form has an approved label. | PepLabo pre-fills nothing: the calculator has no default amount, and the use period after mixing stays empty until you enter it. |
| The only registered human trial was terminated [2]. | The library entry lists the status with sources and dates, so you can see what has changed. |
What PepLabo does and does not do
| PepLabo does | PepLabo does not |
|---|---|
| Record each dose with the date, time and amount you enter, and the site for injections | Suggest a dose, a schedule change or a medicine |
| Remind you 15 minutes before, at the dose time, and 30 minutes after a missed dose | Tell you what to do after a missed dose; the leaflet and your prescriber do |
| Put check-ins, weight and doses on one timeline | Interpret symptoms or judge progress |
| Keep your records on your phone, with no account needed to track | Use analytics, advertising or tracking SDKs, or write to Apple Health |
| Create a PDF of your dose log for your clinician (Pro) | Replace your clinician or pharmacist |
